INTRODUCTION

Oxidative stress in pathological states
Reactive oxygen and nitrogen species are products of the normal cellular metabolism and play important roles in various physiological processes. Under normal conditions, the cell maintains a balance between the prooxidants and antioxidants, a state referred to as "redox balance" or "redox homeostasis". Defense mechanisms against elevated concentrations of reactive species involve enzymatic antioxidants such as superoxide dismutase, catalase, glutathione peroxidase and the peroxiredoxinthioredoxin-thioredoxin reductase system; and nonenzymatic scavenging antioxidants, represented by reduced glutathione (GSH), alfa-tocopherol (vitamin E), urate and other antioxidants.
Oxidative stress is defined as a disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage to nucleic acids, lipids and proteins.
Oxidative modifications of these biomolecules can be detected in cardiovascular (e.g. hypertension, obesity and atherosclerosis), renal (chronic kidney disease (CKD) and end-stage renal disease (ESRD)) and pulmonary diseases (e.g. asthma and cystic fibrosis), and also in cancer and diabetes. These modified molecules can serve as representative biomarkers of the oxidative/nitrosative damage involved in the pathophysiology of the diseases.
The definition of juvenile hypertension is based on the normative distribution of blood pressure (BP) in healthy children, as a systolic and/or diastolic BP ≥ 95 th percentile for age, gender and height (on at least three separate occasions). The prevalence of hypertension in childhood and adolescence (about 3% in 2006) is showing an increasing trend, which is in part attributable to the high prevalence of obesity. BP and weight show tracking from childhood into adulthood, which further emphasizes the importance of juvenile hypertension and overweight.
The prevalence of overweight in adolescents varies from under 5% to more than 20%, the exact number being dependent on geographical and ethnical factors, and the definition of obesity itself. The body mass index (BMI) is the parameter most widely 4 used to assess childhood overweight, even if it is only an indirect measure of adiposity.
Due to the fact that the BMI in children varies greatly with age and sex, percentiles, or age and sex-specific cut-off points are used to define childhood overweight and obesity.
The interrelation between overweight and hypertension is complex, involving (among others) activation of the sympathetic and renin-angiotensin-aldosterone systems, and various metabolic and vascular changes (e.g. insulin resistance, decreased nitric oxide availability and renal sodium excretion, and increased levels of plasma lipids and endothelin-1). These effects have been suggested to be mediated, in part, by hyperleptinemia and leptin resistance in obesity. We earlier demonstrated that oxidative stress is an important feature in juvenile hypertension with or without obesity, and that a short-term antihypertensive treatment can reveal differences in markers of oxidative stress and endothelial dysfunction between lean or obese hypertensive adolescents.
These finding suggest that the pathomechanisms of juvenile hypertension associated with normal body weight or obesity may differ.
The incidences of CKD and ESRD show increasing trends, in part due to the ever more frequent prevalence of their underlying diseases, in particular diabetes. Besides classical cardiovascular risk factors (e.g. diabetes, hypertension and dyslipidemia), uremia-associated factors such as a chronic volume expansion, inflammation, oxidative stress and anemia also play roles. Uremia itself is regarded as a prooxidant state, and the oxidative stress becomes more severe together with the severity of CKD. Despite beneficial effects due to the removal of uremic toxins and excess fluid, hemodialysis (HD) sessions may themselves induce repetitive bouts of oxidative stress. Anemia is a common feature of CKD and ESRD, and is associated with elevated levels of morbidity and mortality in HD patients. The fundamental treatment choices in anemia correction are the administration of erythropoiesis-stimulating agents (ESAs), iron and adjuvant vitamins, and in HD patients, optimization of the dialysis process. Despite a transient increase in the levels of oxidative markers after the initiation of ESA therapy (preventable with simultaneous vitamin E administration), long-term ESA treatment is thought to have antioxidant effects, though the mechanisms have not been well established.
Assessment of the vascular system in pathological states
Among the various techniques developed for the assessment of large vessels, the measurement of arterial stiffness is being increasingly used in the clinical setting. The carotid-femoral pulse wave velocity (PWV; considered the gold-standard measurement of arterial stiffness) is elevated in adult patients with obesity and uncomplicated essential hypertension, and in those on HD, and was shown to be of independent predictive value for all-cause mortality, cardiovascular morbidity, coronary events and stroke. 6 LDF, in turn, allows continuous monitoring of the flux at a specified point of the skin, offers higher sensitivity and has the ability to detect rapid perfusion changes. Due to the relatively large spatial and temporal variabilities of the technique, the response of the microvessels to provocation tests is assessed, instead of the basal flux. These tests include thermal challenges (local or systemic heating or cooling), iontophoretic administration of vasoactive drugs, the PORH test, or a combination of them.
The skin microvascular reactivity, as measured by means of the laser Doppler technique, has been reported to correlate with other methods applied to assess the vascular function in distinct vascular beds, including brachial artery FMD and transthoracic coronary echocardiography. The functional impairment of the microvascular system in HD affects both the endothelium-dependent and -independent vasodilations. In contrast, only the endothelium-dependent microvascular reactivity is affected in adult hypertension, whereas the endothelium-independent function is preserved. Although LDF is highly appropriate for the examination of children and adolescents (due to its simple, convenient and painless nature), no data were available regarding the functional properties of the microvasculature in juvenile essential hypertension before our studies. 
Microvascular reactivity assessment -laser Doppler flowmetry
Microvascular reactivity studies were performed in a temperature-controlled room (24 °C) between 9 a.m. and noon, the subjects being in the fasted state. They were lying in a supine position with their feet at the heart level. After a 15-min equilibration, the volar surface of the right forearm (in HD patients, the forearm contralateral to the Cimino fistula) was gently cleaned with alcohol. The microvascular perfusion of the skin was continuously measured at two sites (distance of separation: 6-8 cm) by means 8
Flux values at baseline and in the plateau phase of the local heating response were evaluated by averaging 60-s intervals. Average values of 20-s intervals were used as peak perfusion responses after each iontophoretic dose. All counted perfusion values were expressed relative to the baseline values (baseline=100%). The within-subject variabilities determined at fixed skin sites of healthy young subjects were 15-25% for both iontophoretic and local thermal provocations in our laboratory.
In order to validate the LDF protocol in the clinical setting, the microvascular reactivities of 12 HD patients were assessed. In agreement with the literature, the endothelium-dependent and -independent vasodilation both proved to be markedly diminished as compared with those in healthy young subjects (data not published). The study protocol was well tolerated by both the patients and the controls, and no adverse local events (pain or red flare) or systemic effects (change in BP, heart rate or respiratory rate) were observed.
Laboratory determinations
In Study 1 (Microvascular reactivity in lean, overweight and obese hypertensive adolescents), venous blood was obtained prior to the LDF measurements. In Study 2
(Erythropoiesis-stimulating agent withdrawal and oxidative stress in hemodialysis), we used blood samples drawn from the arterial line of the dialysis tubes either at the end of the long interdialytic period (biochemical markers) or during routine mid-week blood sampling (hematological parameters), respectively.
Whole blood levels of oxidized glutathione (GSSG) and GSH were assayed by means of a spectrophotometric enzymatic recycling method. Plasma alfa-tocopherol and erythrocyte malondialdehyde (E-MDA) were determined by means of high-performance liquid chromatography, and a variable-wavelength ultraviolet-visible detector. The levels of plasma alfa-tocopherol are reported relative to the total cholesterol plus triglyceride levels. The activities of the erythrocyte SOD (E-SOD) and CAT (E-CAT)
were measured with spectrophotometric methods, and are given relative to the protein concentration of the sample (determined by means of spectrophotometry). Plasma levels of the total, high-and low-density lipoprotein (HDL and LDL) cholesterol and 9 triglycerides, as well as hemoglobin (Hb) levels, proportions of reticulocytes, transferrin saturation values and ferritin levels, were determined with standard laboratory methods.
Study groups and interventions
Microvascular reactivity in lean, overweight and obese hypertensive adolescents (Study 1)
Hypertension was defined as a 24-h systolic and/or diastolic mean BP equal to or greater than the 95 and qualitative blood count in any of the patients or controls. Written informed consent was obtained from the patients, the controls and their parents prior to the study, which was approved by the Ethical Committee of the University of Szeged.
Erythropoiesis-stimulating agent withdrawal and oxidative stress in hemodialysis (Study 2)
Twenty-one patients on chronic HD were enrolled in Study 2, dialyzed in two distinct morning shifts (11 patients: age (mean)±SD 59.3±17.7 yrs, time on HD:
3.6±2.0 yrs; and 10 patients: age 56.6±13.6 yrs, time on HD: 4.3±2.1 yrs, respectively).
All patients were on 4-h bicarbonate HD, performed on a Polyflux 21L dialyzer, The patients had been receiving epoetin beta twice weekly. As part of the treatment strategy, the latter 10 patients were to be switched to darbepoetin alfa, independently from the present study. Epoetin beta therapy was withdrawn for 14 days, after which ESA administration was resumed either with epoetin beta (11 patients, dose: 5000 IU twice a week), or with darbepoetin alfa (10 patients, dose: 50 µg once weekly after the first dialysis of the week), administered in subcutaneous bolus injections at the end of the dialysis. If the transferrin saturation of a patient fell below 30%, 62.5 mg iron gluconate was given intravenously during each of five consecutive dialysis sessions.
Written informed consent was obtained from the patients prior to their entering the study, approved by the Ethical Committee of the University of Szeged.
Statistical analysis
The results are reported as medians (ranges) and means±SD for Studies 1 and 2, respectively. Statistical analyses were performed with GraphPad Prism 4.00 software (GraphPad Software Inc., La Jolla, CA, USA). Statistical comparisons included the nonparametric Kruskal-Wallis test, followed by Dunn's multiple comparison test (Study 1), or repeated-measures two-way analysis of variance, followed by Bonferroni's post hoc test (Study 2). For both studies, a p value <0.05 was considered significant.
RESULTS
Microvascular reactivity in lean, overweight and obese hypertensive adolescents (Study 1)
The plasma levels of HDL cholesterol were significantly elevated in the LH group, and significantly decreased in the OBH patients (both p<0.05 vs the controls). The plasma triglyceride levels were higher in the OWH and OBH patients as compared with the controls (p<0.05 and p<0.01, respectively). The plasma HDL cholesterol and triglyceride levels in the OBH group were also higher than those in the LH subjects (p<0.01 and p<0.05, respectively). The mean age, diastolic BP and plasma levels of total and LDL cholesterol were similar in the study groups.
The whole blood ratios oxidized/reduced glutathione (GSSG/GSH) were significantly elevated in all the patient groups (all p<0.001 vs the controls). Also, the ratios GSSG/GSH in the OBH group were higher than those in the LH subjects (p<0.05). The activities of E-CAT were increased in the OWH group as compared with the controls (p<0.05). The levels of plasma alfa-tocopherol (relative to the total cholesterol plus triglyceride levels) and E-MDA, and the activities of E-SOD were similar in the study groups.
As concerns laser Doppler flowmetry measurements, the perfusion increments after iontophoresis of the endothelium-dependent vasodilator ACH did not differ significantly in the patient groups and the controls. In contrast, the second iontophoretic dose of the endothelium-independent vasodilator SNP increased the microvascular blood flux to a significantly smaller extent in the LH group than in the controls (482.5% 
Erythropoiesis-stimulating agent withdrawal and oxidative stress in hemodialysis (Study 2)
The Hb levels were decreased at week 6 in both groups (p<0.05 vs the baseline), and had returned to the initial values by week 14. The proportion of reticulocytes exhibited a decrease at week 2 and a subsequent elevation at weeks 6 and 10 (all p<0.05 vs the baseline). No differences were observed between the groups in either parameter. The transferrin saturation values and the levels of ferritin were not changed in either group.
The ratios GSSG/GSH were significantly increased at weeks 2 and 6 in both groups (all p<0.001 vs the baseline), but had returned to the initial levels by week 14. Similar tendencies were found in the levels of GSSG. The GSH concentrations were increased at week 14 in the two groups (p<0.001 vs the baseline). The E-MDA levels exhibited an elevation at week 6 (p<0.01 vs the baseline) and a subsequent return to the initial levels by week 14 in both groups. As compared with the baseline values, the activities of E-SOD were reduced significantly at week 6 in both study groups (p<0.001), and had returned to the baseline by week 14. The activities of E-CAT were significantly increased at week 14 in both groups (p<0.001 vs the baseline).
CONCLUSIONS AND ORIGINAL FINDINGS
1. The endothelium-dependent microvascular reactivity is not significantly attenuated in hypertensive adolescents being lean, overweight or obese. This finding suggests that, in the pathogenesis of juvenile essential hypertension, an impairment of the endothelium-dependent microvascular reactivity is more likely to follow, rather than precede the elevation of the BP.
2. The endothelium-independent vasodilation is significantly impaired in the LH and OBH groups, but not in the OWH patients, as compared with the controls.
3. The microvascular reactivities are not related to differences in the levels of oxidative markers, even if the presence of an increased oxidative stress is confirmed in all the hypertensive groups.
4. An increased oxidative stress is revealed by significantly elevated ratios GSSG/GSH directly after the withdrawal of epoetin beta treatment in HD patients.
5. The levels of GSSG/GSH, GSSG and E-MDA are significantly increased and the activities of E-SOD are significantly decreased four weeks after darbepoetin alfa or epoetin beta therapy resumption as compared with the baseline.
6. The levels of GSSG/GSH, GSSG and E-MDA return to the baseline values by the end of the 12-week follow-up, parallelled with increased GSH and E-CAT activity levels.
7. The opposite trend in the levels of Hb and oxidative markers, and similarities in the time courses and magnitudes of the oxidative alterations during the treatment with different ESAs suggest that the observed changes may primarily be caused by factors associated with the correction of anemia, rather than the direct effect of ESA.
This emerging hypothesis is yet to be confirmed. 
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